相关实验视频
Updated: Jul 18, 2025

12:43
On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
11.0K
通过HT-C6抑制内皮炎症反应,HT-C6是一种氧铁醇乙烯衍生物
Ana Dácil Marrero1,2,3, Laura Castilla1,2, Manuel Bernal1,2
1Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, Andalucía Tech, 29071 Málaga, Spain.
Antioxidants (Basel, Switzerland)
|August 26, 2023
概括
氧醇衍生物HT-C6通过抑制NF-κB通路和减少活性氧物种 (ROS) 有效地减少内皮细胞的炎症. 这种抗氧化化合物对治疗动脉样硬化有很大的前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 氧醇 (HT) 是一种在橄和EVOO中发现的强有力的抗氧化剂.
- 半合成HT衍生物,如HT-C6,显示出希望,但它们的抗炎作用尚未被探索.
- 内皮细胞炎症是动脉样硬化发展的关键因素.
研究的目的:
- 研究HT-C6在内皮细胞 (ECs) 中的抗炎潜力.
- 阐明HT-C6在减少炎症中的作用机制.
- 评估HT-C6对反应性氧物种 (ROS) 生产的影响.
主要方法:
- 对炎症标记物的基因表达分析 (RT-qPCR).
- 关键信号通路的蛋白质分析 (西方污点,免疫光).
- 功能测试用于细胞粘附,迁移和ROS监测.
主要成果:
- 在HUVEC中,HT-C6显著降低了TNF-α诱导的VCAM1,ICAM1,SELE,CCL2和CCL5的表达.
- HT-C6 损害了单细胞粘附和向ECs的化学反应.
- 在EC中,HT-C6取消了NF-κB通路激活,并减少了ROS形成.
结论:
- 在内皮细胞中,HT-C6表现出显著的抗炎特性.
- 该机制涉及NF-κB抑制和ROS降低.
- 在动脉样硬化治疗中,HT-C6是进一步研究的有希望的候选者.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
201
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
203
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
203
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
215
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
215
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751

